FEBRUARY 17 TH 2017 NAPLES Hotel Royal Continental Director: 6.6 CME Credits
Addressed to The meeting is addressed to oncologists specialized in colorectal cancer. Objectives The therapeutical choice for patients with mcrc is becoming harder because of the availability of four chemotherapic agents and five biological drugs. The therapeutical approach requires the definition of the therapeutic strategy that must consider the tumor and the patients features. In order to take the right decision, we also need to consider that the choice includes various other decisions: how to continue first- line treatment after induction therapy how to carry on maintenance therapy when it is possible to talk about second-line biological drugs: which one and when metastasis resection: when All these key issues will be discussed by an Internationally renowned panel. Director Cattedra di Oncologia Medica Speakers and Chairmen Dirk Arnold Serviço de Oncologia I.C.O. Instituto CUF de Oncologia Lisbon (P) Giulio Belli U.O.C. di Chirurgia Generale Epato-bilio-pancreatica e D Urgenza P.O.S. Maria di Loreto Nuovo ASL Na 1 Centro Johanna Bendell Sarah Cannon Research Institute Tennessee Oncology Nashville (USA) Erika Martinelli Oncologia Medica Vincenzo Sforza Oncologia Medica Teresa Troiani Oncologia Medica Axel Grothey Department of Oncology Mayo Clinic Rochester (USA)
PROGRAM Friday, 17 th February 09.30 Registration and welcome 10.00 Meeting introduction International panel discus and their impact o 10.10 ESMO guidelines about patient treatment with mcrc 10.30 How to optimize first-line therapy Axel Grothey 11.05 Coffee break 11.15 How to choose the right second-line treatment Dirk Arnold 11.50 Beyond first and second-line treatments How do we treat refractory disease and what new treatments are on the horizon? Johanna Bendell 12.25 Oncologists working together with Surgeons: a winning synergy Giulio Belli 13.00 Lunch
sion on new scientific evidence n mcrc clinical practice 14.00 Interactive session with international experts Participants will be divided into groups, each group will attend every session; each teamwork lasts 45 minutes Teamwork How to optimize first-line therapy Expert: Axel Grothey Chairman: Erika Martinelli Teamwork How to choose the right second-line treatment Expert: Dirk Arnold Chairman: Teresa Troiani Teamwork How to define and manage elderly/unfit patients Expert: Johanna Bendell Chairman: Vincenzo Sforza 16.15 Coffee break 16.30 Plenary session: results of teamwork Erika Martinelli, Teresa Troiani, Vincenzo Sforza 17.15 Take home messages 17.30 Final evaluation CME test International - Meet the Experts and SHare clinical practice
CME Based on the in force Italian regulations, Accademia Nazionale di Medicina (provider n.31) assigns 6.6 CME credits to this activity (31-178692). The meeting is addressed to physicians specialized in oncology. It will not be possible to give credits to physicians specialized in different fields. The credit certification is subject to: attendance at the meeting; the completion of the meeting evaluation form; the completion of the final questionnaire (at least 75% of correct answer). Official language The meeting will be held in Italian and English. Simultaneous translation will be provided. Registration Participation in the meeting is free and is addressed to a limited number of participants. To register, please send: registration form duly filled out privacy statement and consent regarding personal information (back of the form) to Accademia Nazionale di Medicina - Via M. Piaggio 17/6, 16122 Genova - fax. 010 83794260 - e-mail: segreteriacorsi@accmed.org The registration will be confirmed by e-mail, please indicate your e-mail address on the registration form. Meeting Venue Hotel Royal Continental Via Partenope 38/44 Promoted by ACCADEMIA NAZIONALE DI MEDICINA www.accmed.org General Manager: Stefania Ledda Information Ph. +39 010 83794224 Fax +39 010 83794260 segreteriacorsi@accmed.org Organizing partner Forum Service Via M. Piaggio 17/6 16122 Genova (I) With the unconditioned contribution of